Trial
NCT04244058
Changes in Glutamatergic Neurotransmission of Severe TBI Patients
Early Phase ISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Weill Medical College of Cornell University
Collaborators
—
Condition
Disorder of Consciousness
Intervention
Amantadine + L-DOPA
Why stopped
Given CoVid-19 pandemic we could not recruit subjects/patients for the 1st year. Currently waiting for new sponsor to fulfill the aims.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-09-30